Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2024-04-16 Major Shareholding Noti…
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Change in substantial holding 3 pages 243.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001 Section 671B. It details changes in voting power and relevant interests of a substantial shareholder in PYC Therapeutics Limited, including dates and shareholding percentages. This type of filing is a notification of changes in major shareholding levels, which corresponds to the category Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report, but a regulatory notice about shareholding changes.
2024-04-16 English
Update - Application for quotation of securities - PYC 6 pages 18.4KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX. It details updates to a previous announcement regarding the issuance and quotation of shares as part of a capital raising transaction. The content focuses on the specifics of securities issued, issue dates, and the number of shares to be quoted. This type of document is related to capital raising and changes in the company's capital structure rather than a financial report or earnings release. It is not a full financial report, audit, or management discussion. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive update on capital raising.
2024-04-14 English
Application for quotation of securities - PYC 5 pages 16.7KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX. It details the number and type of securities to be quoted, issue dates, and references a previous Appendix 3B announcement related to the securities issuance. The document is an official announcement related to capital market activity, specifically the quotation of newly issued shares. It does not contain financial statements, management discussion, or audit information. It is not a report but an announcement of a capital market transaction. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is under 5,000 characters, but it is not merely announcing the publication of a report; it is itself an announcement of a capital market event.
2024-04-11 English
Change in substantial holding 2 pages 119.5KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and relevant interests of a substantial shareholder in PYC Therapeutics Limited. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2024-04-10 English
$74.6 Million Extension of Cash Runway 3 pages 269.5KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding the completion and progress of a capital raising event, specifically an Accelerated Non-Renounceable Entitlement Offer (ANREO) by PYC Therapeutics Limited. It details the amounts raised, the retail component results, institutional commitments, and settlement dates for new shares. There is no detailed financial report, earnings data, or management discussion of financial results. The focus is on fundraising and capital structure changes. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length (6636 characters) and content confirm it is a full announcement rather than a brief notice or a report publication announcement.
2024-04-09 English
Notification of cessation of securities - PYC 4 pages 15.0KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation (lapse) of certain securities (options) for PYC Therapeutics Limited. It includes specific information about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is an official announcement related to changes in the company's securities, specifically the cessation of certain options. It does not contain financial statements, management discussion, or other report content. It is a regulatory announcement about securities cessation, which fits best under the category of Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories like share issue or capital change (SHA) or director dealings (DIRS). The document length is 4310 characters, which is relatively short and consistent with an announcement rather than a full report.
2024-04-02 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.